Peter C Wever Selected Research

Q Fever (Fever, Q)

11/2022	Fluorescence in situ hybridization for detecting Coxiella burnetii in tissue samples from chronic Q fever patients.
1/2022	Targeted Screening for Chronic Q Fever, the Netherlands.
1/2022	Differences in local immune cell landscape between Q fever and atherosclerotic abdominal aortic aneurysms identified by multiplex immunohistochemistry.
9/2021	The prognostic value of serological titres for clinical outcomes during treatment and follow-up of patients with chronic Q fever.
1/2019	Pitfalls of molecular diagnostic testing for Coxiella burnetii DNA on throat swabs.
12/2018	Primary and secondary arterial fistulas during chronic Q fever.
10/2018	Viable Coxiella burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella burnetii.
10/2018	Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens.
1/2018	The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever.
1/2016	Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C Wever Research Topics

Disease

25	Q Fever (Fever, Q) 11/2022 - 01/2009
9	Infections 01/2019 - 04/2011
5	COVID-19 01/2022 - 12/2020
5	Pneumonia (Pneumonitis) 01/2019 - 01/2009
3	Infected Aneurysm 12/2018 - 04/2011
3	Endocarditis 01/2018 - 04/2011
3	Inflammation (Inflammations) 11/2014 - 02/2012
2	Sepsis (Septicemia) 01/2019 - 01/2014
2	Aortic Aneurysm (Aneurysm, Aortic) 12/2018 - 01/2010
2	Aneurysm (Aneurysms) 12/2018 - 04/2012
2	Malaria 03/2013 - 12/2002
1	Disease Progression 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Invasive Pulmonary Aspergillosis 01/2022
1	Coinfection 02/2021
1	Lymphoma (Lymphomas) 02/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2018
1	Nontuberculous Mycobacterium Infections 01/2017
1	Staphylococcal Infections 02/2014
1	Hepatitis 01/2014
1	Bacteremia 01/2014
1	Chronic Disease (Chronic Diseases) 06/2013
1	Lymphopenia (Lymphocytopenia) 03/2013
1	Critical Illness (Critically Ill) 03/2013
1	Urinary Tract Infections (Urinary Tract Infection) 03/2013
1	Bacterial Infections (Bacterial Infection) 07/2012
1	Mycoses (Diseases, Fungus) 07/2012
1	Virus Diseases (Viral Diseases) 07/2012
1	Epstein-Barr Virus Infections 07/2012
1	Renal Insufficiency (Renal Failure) 04/2012
1	Hypophosphatemia 02/2012
1	Fever (Fevers) 02/2012
1	Confusion (Bewilderment) 01/2009

Drug/Important Bio-Agent (IBA)

6	C-Reactive ProteinIBA 01/2019 - 01/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 06/2011
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2013
5	Immunoglobulin G (IgG)IBA 01/2022 - 06/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2010
3	AntibodiesIBA 01/2015 - 06/2011
2	ProcalcitoninIBA 01/2019 - 01/2009
2	Interleukin-10 (Interleukin 10)IBA 10/2018 - 02/2018
2	CytokinesIBA 10/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 09/2015 - 06/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2015 - 11/2014
2	Interleukin-18 (Interleukin 18)IBA 06/2015 - 07/2012
2	EnzymesIBA 01/2014 - 06/2011
1	SteroidsIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Vitamin K FDA Link 11/2021
1	AnticoagulantsIBA 11/2021
1	Viral ProteinsIBA 01/2021
1	Mannose ReceptorIBA 01/2019
1	TetracyclinesIBA 10/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2018
1	Interleukin-6 (Interleukin 6)IBA 10/2018
1	QuinolonesIBA 10/2018
1	16S Ribosomal RNAIBA 02/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	beta-lactamase NDM-1IBA 01/2017
1	NucleotidesIBA 09/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2015
1	Pattern Recognition ReceptorsIBA 09/2015
1	IntegrinsIBA 09/2015
1	Interferon-gamma (Interferon, gamma)IBA 06/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2015
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2014
1	Panton-Valentine leukocidinIBA 02/2014
1	Alanine Transaminase (SGPT)IBA 01/2014
1	BilirubinIBA 01/2014
1	VaccinesIBA 12/2013
1	Ferritins (Ferritin)IBA 07/2012
1	AntigensIBA 06/2011
1	Immunoglobulin M (IgM)IBA 06/2011
1	ImmunosorbentsIBA 06/2011
1	Urea (Carbamide)FDA LinkGeneric 01/2009
1	hemozoinIBA 12/2002

Therapy/Procedure

4	Blood Vessel Prosthesis 12/2018 - 04/2011
4	Prostheses and Implants (Prosthesis) 12/2018 - 01/2010
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Therapeutics 09/2021
1	Plasmapheresis 12/2020
1	Catheters 01/2017
1	Peritoneal Dialysis 01/2017
1	Antibiotic Prophylaxis 02/2014
1	Vascular Surgical Procedures 04/2012
1	Length of Stay 02/2012